Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. 2020

Fabio Facchinetti, and Vittorio Unfer, and Didier Dewailly, and Zdravko A Kamenov, and Evanthia Diamanti-Kandarakis, and Antonio Simone Laganà, and John E Nestler, and Christophe O Soulage, and
Department of Obstetrics and Gynecology and Pediatrics, University of Modena and Reggio Emilia, Modena, Italy. Electronic address: fabio.facchinetti@unimore.it.

This review details the physiologic roles of two insulin sensitizers, myo-inositol (MI) and d-chiro-inositol (DCI). In the human ovary, MI is a second messenger of follicle-stimulating hormone (FSH) and DCI is an aromatase inhibitor. These activities allow a treatment for polycystic ovary syndrome (PCOS) to be defined based on the combined administration of MI and DCI, where the best MI:DCI ratio is 40:1. Moreover, MI enhances the effect of metformin and clomiphene on the fertility of PCOS women seeking pregnancy. As impaired intestinal transport may lead to unsuccessful inositol treatment, we also discuss new data on the use of alpha-lactalbumin to boost inositol absorption. Overall, the physiological activities of MI and DCI dictate the dosages and timing of inositol supplementation in the treatment of PCOS.

UI MeSH Term Description Entries
D007294 Inositol An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction. Myoinositol,Chiro-Inositol,Mesoinositol,Chiro Inositol
D011085 Polycystic Ovary Syndrome A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. Stein-Leventhal Syndrome,Polycystic Ovarian Syndrome,Polycystic Ovary Syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary Syndrome,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,Sclerocystic Ovary,Stein Leventhal Syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014803 Vitamin B Complex A group of water-soluble vitamins, some of which are COENZYMES. B Vitamin,B Vitamins,Neurobion,Vitamin, B

Related Publications

Fabio Facchinetti, and Vittorio Unfer, and Didier Dewailly, and Zdravko A Kamenov, and Evanthia Diamanti-Kandarakis, and Antonio Simone Laganà, and John E Nestler, and Christophe O Soulage, and
January 2016, Indian journal of endocrinology and metabolism,
Fabio Facchinetti, and Vittorio Unfer, and Didier Dewailly, and Zdravko A Kamenov, and Evanthia Diamanti-Kandarakis, and Antonio Simone Laganà, and John E Nestler, and Christophe O Soulage, and
February 2011, Journal of pharmacy practice,
Fabio Facchinetti, and Vittorio Unfer, and Didier Dewailly, and Zdravko A Kamenov, and Evanthia Diamanti-Kandarakis, and Antonio Simone Laganà, and John E Nestler, and Christophe O Soulage, and
January 2017, Frontiers in pharmacology,
Fabio Facchinetti, and Vittorio Unfer, and Didier Dewailly, and Zdravko A Kamenov, and Evanthia Diamanti-Kandarakis, and Antonio Simone Laganà, and John E Nestler, and Christophe O Soulage, and
January 1990, Hormone research,
Fabio Facchinetti, and Vittorio Unfer, and Didier Dewailly, and Zdravko A Kamenov, and Evanthia Diamanti-Kandarakis, and Antonio Simone Laganà, and John E Nestler, and Christophe O Soulage, and
November 2016, Best practice & research. Clinical obstetrics & gynaecology,
Fabio Facchinetti, and Vittorio Unfer, and Didier Dewailly, and Zdravko A Kamenov, and Evanthia Diamanti-Kandarakis, and Antonio Simone Laganà, and John E Nestler, and Christophe O Soulage, and
July 2020, International journal of molecular sciences,
Fabio Facchinetti, and Vittorio Unfer, and Didier Dewailly, and Zdravko A Kamenov, and Evanthia Diamanti-Kandarakis, and Antonio Simone Laganà, and John E Nestler, and Christophe O Soulage, and
December 2021, Journal of the Turkish German Gynecological Association,
Fabio Facchinetti, and Vittorio Unfer, and Didier Dewailly, and Zdravko A Kamenov, and Evanthia Diamanti-Kandarakis, and Antonio Simone Laganà, and John E Nestler, and Christophe O Soulage, and
January 1990, Hormone research,
Fabio Facchinetti, and Vittorio Unfer, and Didier Dewailly, and Zdravko A Kamenov, and Evanthia Diamanti-Kandarakis, and Antonio Simone Laganà, and John E Nestler, and Christophe O Soulage, and
September 2001, Expert opinion on investigational drugs,
Fabio Facchinetti, and Vittorio Unfer, and Didier Dewailly, and Zdravko A Kamenov, and Evanthia Diamanti-Kandarakis, and Antonio Simone Laganà, and John E Nestler, and Christophe O Soulage, and
June 2008, Human reproduction (Oxford, England),
Copied contents to your clipboard!